Nature Medicine, Published online: 22 December 2025; doi:10.1038/s41591-025-04114-7
An implantable vagus nerve-targeted device safely reduces disease activity and joint damage in rheumatoid arthritis, offering a new nondrug treatment for patients who do not respond to or cannot tolerate medication.
